Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs

This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.

Detalles Bibliográficos
Autores principales: Shahid, Izza, Khan, Muhammad Shahzeb, Sohail, Aruba, Khan, Safi U., Greene, Stephen J., Fudim, Marat, Michos, Erin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881772/
https://www.ncbi.nlm.nih.gov/pubmed/35212753
http://dx.doi.org/10.1001/jamanetworkopen.2022.0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881772/
https://www.ncbi.nlm.nih.gov/pubmed/35212753
http://dx.doi.org/10.1001/jamanetworkopen.2022.0035

Ejemplares similares